Decoy Therapeutics Inc.
DCOY
$5.15
-$0.29-5.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 122.67% | 505.07% | -55.80% | -26.13% | -25.87% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 83.10% | 174.27% | -75.15% | -33.48% | -38.45% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 77.49% | 78.16% | 29.15% | -- |
| Total Current Assets | 81.13% | 346.08% | -41.02% | -22.84% | -21.84% |
|
|
|||||
| Total Current Assets | 81.13% | 346.08% | -41.02% | -22.84% | -21.84% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -3.43% | -3.31% | -3.21% | -3.11% | -3.01% |
| Total Assets | 81.35% | 337.75% | -40.46% | -22.61% | -21.67% |
|
|
|||||
| Total Accounts Payable | -14.82% | -25.49% | 0.76% | 56.96% | 465.14% |
| Total Accrued Expenses | 15.39% | 0.57% | 6.62% | 97.11% | -19.89% |
| Short-term Debt | -- | -- | -- | -49.44% | -32.51% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 179.49% | -16.81% | -2.41% | 50.70% | 61.71% |
|
|
|||||
| Total Current Liabilities | 179.49% | -16.81% | -2.41% | 50.70% | 61.71% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -49.44% | -32.51% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 179.49% | -16.81% | -2.41% | 50.70% | 61.71% |
|
|
|||||
| Common Stock & APIC | 11.84% | 7.10% | 0.08% | 0.31% | 0.06% |
| Retained Earnings | -10.50% | -1.03% | -1.15% | -2.09% | -1.82% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 38.63% | 612.00% | -1,440.39% | -95.91% | -48.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 38.63% | 612.00% | -1,440.39% | -95.91% | -48.31% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 38.63% | 612.00% | -1,440.39% | -95.91% | -48.31% |
|
|
|||||